Serenace



Indications and Reactions:

Role Indications Reactions
Primary
Cancer Pain 18.8%
Constipation 12.5%
Delirium 12.5%
Drug Use For Unknown Indication 12.5%
Haemoptysis 12.5%
Benign Prostatic Hyperplasia 6.3%
Gastritis Prophylaxis 6.3%
Hypertension 6.3%
Non-small Cell Lung Cancer 6.3%
Psychotic Disorder 6.3%
Death 25.0%
Pneumonitis 25.0%
Product Name Confusion 25.0%
Tremor Neonatal 25.0%
Secondary
Schizophrenia 32.6%
Product Used For Unknown Indication 12.5%
Drug Use For Unknown Indication 11.9%
Depression 5.4%
Epilepsy 4.5%
Constipation 4.1%
Insomnia 3.2%
Attention Deficit/hyperactivity Disorder 3.0%
Nausea 2.6%
Autism 2.2%
Delirium 2.2%
Delusion 2.1%
Convulsion 1.9%
Hallucination 1.9%
Prophylaxis 1.9%
Cancer Pain 1.7%
Parkinsonism 1.7%
Pharyngitis 1.7%
Fluid Replacement 1.5%
Pyrexia 1.5%
Neuroleptic Malignant Syndrome 14.6%
Pneumonia 9.0%
Sydenham's Chorea 9.0%
Toxic Epidermal Necrolysis 6.7%
Metabolic Encephalopathy 5.6%
Off Label Use 4.5%
Persecutory Delusion 4.5%
Platelet Count Increased 4.5%
Psychomotor Skills Impaired 4.5%
Pulmonary Embolism 4.5%
Urinary Retention 4.5%
Vomiting 4.5%
Agranulocytosis 3.4%
Cardiac Failure Acute 3.4%
Death 3.4%
Depressed Level Of Consciousness 3.4%
Respiratory Failure 3.4%
Hepatic Function Abnormal 2.2%
Insomnia 2.2%
Liver Disorder 2.2%
Concomitant
Schizophrenia 14.5%
Insomnia 9.9%
Drug Use For Unknown Indication 9.8%
Cancer Pain 8.4%
Product Used For Unknown Indication 6.9%
Constipation 6.8%
Schizophrenia, Undifferentiated Type 6.1%
Prophylaxis 5.7%
Delirium 4.1%
Pneumonia 3.4%
Nausea 3.0%
Schizophrenia, Paranoid Type 3.0%
Hypertension 2.9%
Depression 2.8%
Multiple Myeloma 2.4%
Epilepsy 2.3%
Analgesic Therapy 2.2%
Pain 2.1%
Diabetes Mellitus 1.9%
Hiv Infection 1.8%
Renal Impairment 11.6%
Shock 11.1%
White Blood Cell Count Decreased 10.6%
Vomiting 6.8%
Weight Decreased 6.3%
White Blood Cell Count Increased 6.3%
Nausea 5.3%
Respiratory Failure 4.3%
Sepsis 4.3%
Pyrexia 3.9%
Thrombocytopenia 3.9%
Wrong Technique In Drug Usage Process 3.9%
Hepatic Function Abnormal 2.9%
Malaise 2.9%
Pulmonary Embolism 2.9%
Tri-iodothyronine Decreased 2.9%
Weight Increased 2.9%
Acute Respiratory Distress Syndrome 2.4%
Delirium 2.4%
Interstitial Lung Disease 2.4%
Interacting
Schizophrenia 50.0%
Local Anaesthesia 16.7%
Cognitive Disorder 8.3%
Constipation 8.3%
Depression 8.3%
Peptic Ulcer 8.3%
Pancytopenia 33.3%
Withdrawal Syndrome 33.3%
Drug Interaction 16.7%
Post Procedural Complication 16.7%